Fructose and/or Sorbitol Intolerance in a Subgroup of Lactose Intolerant Patients

The diagnosis and treatment of lactose intolerance often does not resolve all the symptoms of postcibal bloating and flatulence. Included in this study were 104 lactose intolerant patients (71 female, 33 male) who complained of residual postcibal discomfort in spite of adherence to and benefit from...

Full description

Saved in:
Bibliographic Details
Main Authors: SR Mishkin, L Sablauskas, S Mishkin
Format: Article
Language:English
Published: Wiley 1994-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1994/703728
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567109366841344
author SR Mishkin
L Sablauskas
S Mishkin
author_facet SR Mishkin
L Sablauskas
S Mishkin
author_sort SR Mishkin
collection DOAJ
description The diagnosis and treatment of lactose intolerance often does not resolve all the symptoms of postcibal bloating and flatulence. Included in this study were 104 lactose intolerant patients (71 female, 33 male) who complained of residual postcibal discomfort in spite of adherence to and benefit from appropriate measures for their documented lactose intolerance (at least 20 ppm H2 after 25 g lactose as well as appropriate symptomatic discomfort). Clinical characteristics common to this group included: symptomatic diarrhea (12.5%), history of foreign travel (5.8%), endoscopic and pathological evidence of gastritis and helicobacter infection (19.2 and 8.7%, respectively), nonspecific abnormalities of small bowel follow-through (15.4%), Crohn’s disease (8.7%) and colonic cliverticulosis (14.4%). Intolerance co fructose (at least 10 ppm H2 after 25 g fructose plus appropriate symptoms) or sorbitol (at least 10 ppm H2 after 5 g sorbitol plus appropriate symptoms) was documented in 17.3 and 18.3%, respectively. Intolerance to both fructose and sorbicol (administered as separate challenges), more than twice as common as intolerance to either one alone, occurred in 41.4% and was independent of sex. In conclusion, additional carbohydrate intolerances contribute to postcibal discomfort in more than 75% of lactose intolerant patients who remain symptomatic in spite of adherence to appropriate measures for this condition. While 62% of all patients had benefited significantly (greater than 50%) from appropriate dietary measures and enzyme replacement for lactose intolerance, only 40% of those who were also fructose intolerant and 47% who were sorbitol intolerant benefited (greater than 50%) from appropriate dietary measures (no enzyme replacement yet available) for intolerance to these sugars.
format Article
id doaj-art-87241880347e47fea45ea86076a9ef0b
institution Kabale University
issn 0835-7900
language English
publishDate 1994-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-87241880347e47fea45ea86076a9ef0b2025-02-03T01:02:16ZengWileyCanadian Journal of Gastroenterology0835-79001994-01-018638939310.1155/1994/703728Fructose and/or Sorbitol Intolerance in a Subgroup of Lactose Intolerant PatientsSR Mishkin0L Sablauskas1S Mishkin2Division of Gastroenterology, Royal Victoria Hospital, Department of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Gastroenterology, Royal Victoria Hospital, Department of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Gastroenterology, Royal Victoria Hospital, Department of Medicine, McGill University, Montreal, Quebec, CanadaThe diagnosis and treatment of lactose intolerance often does not resolve all the symptoms of postcibal bloating and flatulence. Included in this study were 104 lactose intolerant patients (71 female, 33 male) who complained of residual postcibal discomfort in spite of adherence to and benefit from appropriate measures for their documented lactose intolerance (at least 20 ppm H2 after 25 g lactose as well as appropriate symptomatic discomfort). Clinical characteristics common to this group included: symptomatic diarrhea (12.5%), history of foreign travel (5.8%), endoscopic and pathological evidence of gastritis and helicobacter infection (19.2 and 8.7%, respectively), nonspecific abnormalities of small bowel follow-through (15.4%), Crohn’s disease (8.7%) and colonic cliverticulosis (14.4%). Intolerance co fructose (at least 10 ppm H2 after 25 g fructose plus appropriate symptoms) or sorbitol (at least 10 ppm H2 after 5 g sorbitol plus appropriate symptoms) was documented in 17.3 and 18.3%, respectively. Intolerance to both fructose and sorbicol (administered as separate challenges), more than twice as common as intolerance to either one alone, occurred in 41.4% and was independent of sex. In conclusion, additional carbohydrate intolerances contribute to postcibal discomfort in more than 75% of lactose intolerant patients who remain symptomatic in spite of adherence to appropriate measures for this condition. While 62% of all patients had benefited significantly (greater than 50%) from appropriate dietary measures and enzyme replacement for lactose intolerance, only 40% of those who were also fructose intolerant and 47% who were sorbitol intolerant benefited (greater than 50%) from appropriate dietary measures (no enzyme replacement yet available) for intolerance to these sugars.http://dx.doi.org/10.1155/1994/703728
spellingShingle SR Mishkin
L Sablauskas
S Mishkin
Fructose and/or Sorbitol Intolerance in a Subgroup of Lactose Intolerant Patients
Canadian Journal of Gastroenterology
title Fructose and/or Sorbitol Intolerance in a Subgroup of Lactose Intolerant Patients
title_full Fructose and/or Sorbitol Intolerance in a Subgroup of Lactose Intolerant Patients
title_fullStr Fructose and/or Sorbitol Intolerance in a Subgroup of Lactose Intolerant Patients
title_full_unstemmed Fructose and/or Sorbitol Intolerance in a Subgroup of Lactose Intolerant Patients
title_short Fructose and/or Sorbitol Intolerance in a Subgroup of Lactose Intolerant Patients
title_sort fructose and or sorbitol intolerance in a subgroup of lactose intolerant patients
url http://dx.doi.org/10.1155/1994/703728
work_keys_str_mv AT srmishkin fructoseandorsorbitolintoleranceinasubgroupoflactoseintolerantpatients
AT lsablauskas fructoseandorsorbitolintoleranceinasubgroupoflactoseintolerantpatients
AT smishkin fructoseandorsorbitolintoleranceinasubgroupoflactoseintolerantpatients